Clinical Trials Browser

Phase 2 × FED × Clear all

NCT05796375 2026-05-04

ReplaceCysto

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06610825 2026-04-13

CaRPET

Phase 2 Recruiting

Prostatic Neoplasms

NCT05593497 2026-03-27

SNARE

Phase 2 Recruiting

Prostatic Neoplasms

NCT06275360 2026-03-02

RIVAL

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04104893 2026-02-27

CHOMP

Phase 2 Active not recruiting

Turcot syndrome, Prostatic Neoplasms

NCT04515004 2026-02-17

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

Phase 2 Terminated

6 enrolled 3 charts

Early Stage Lung Cancer (I and II)

NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

Phase 2 Recruiting

Prostatic Neoplasms

NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Phase 2 Recruiting

Keratosis, Actinic

NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT06520098 2025-10-14

Benefit VA

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04038502 2025-08-20

COBRA

Phase 2 Recruiting

Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Phase 2 Completed

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer

NCT05011383 2025-07-09

VA-BAT

Phase 2 Recruiting

Prostatic Neoplasms

NCT04390880 2025-05-16

PROSPYL

Phase 2 Completed

239 enrolled 5 charts

Prostatic Neoplasms

NCT01759771 2024-03-18

VD3PCa

Phase 2 Completed

130 enrolled 13 charts

Prostatic Neoplasms

NCT05820724 2023-04-24

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Phase 2 Unknown

Prostate Cancer Diagnosis

NCT04116775 2022-06-23

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Phase 2 Unknown

Neoplasm Metastasis, Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT03753243 2022-04-20

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04489745 2020-07-28

Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01754909 2019-10-08

Mitigation of Radiation Pneumonitis and Fibrosis

Phase 2 Completed

50 enrolled 10 charts

Lung Neoplasms, Radiation Pneumonitis

NCT00780234 2019-04-11

Pioglitazone for Lung Cancer Chemoprevention

Phase 2 Completed

92 enrolled 9 charts

Lung Neoplasms

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

NCT00953225 2017-10-09

vit D & PCa

Phase 2 Completed

83 enrolled 8 charts

Prostatic Neoplasms

NCT00105599 2015-04-07

Effectiveness of the FairCare System for Patients With Advanced Illness

Phase 2 Completed

Neoplasms

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Phase 2 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT00004688 2015-03-25

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Genetic Diseases, Inborn, Rare Diseases

NCT00056992 2015-03-25

Testing of ADI-PEG in Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00086203 2015-03-25

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00098033 2015-03-25

Investigation of Clofarabine in Acute Leukemias

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00099593 2015-03-25

Immunization Against Tumor Cells in Sezary Syndrome

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT01032928 2015-01-01

RSPT

Phase 2 Completed

30 enrolled 9 charts

Deglutition Disorders, Oropharyngeal Neoplasms, Respiratory Aspiration

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Phase 2 Terminated

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT01417806 2011-08-16

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT00018538 2009-01-21

Calcifidol Therapy in Men With Cancer

Phase 2 Completed

Prostatic Neoplasms, Recurrence

NCT00018551 2009-01-21

Chemoprevention With Folic Acid

Phase 2 Completed

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps

NCT00728520 2008-08-06

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00108290 2008-04-04

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00215345 2005-09-22

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT00218205 2005-09-22

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms